Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2023-04-24 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an announcement about regaining compliance with Nasdaq listing requirements, specifically a press release attached as Exhibit 99.1. The document is relatively short (3007 characters) and primarily serves to furnish information rather than provide detailed financial data or comprehensive reports. It does not contain full financial statements or substantive financial analysis. The content is an announcement related to regulatory compliance and listing status, not a full report like an Annual Report or Interim Report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2023-04-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an announcement about a press release regarding the company's plan to submit an IND for a drug in Q2 2023. The document is short (2861 characters) and primarily serves to furnish information rather than provide detailed financial data or a full report. It references an attached exhibit (99.1) which is a news service announcement. There is no substantive financial data, management discussion, or detailed report content. According to the rules, such a document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-04-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a press release announcement about initiating a program to develop a treatment for Type 1 Diabetes. The document is short (2898 characters) and primarily serves to furnish information rather than provide detailed financial data or comprehensive reports. It does not contain financial statements or detailed analysis, nor does it represent an annual or quarterly report. The document is an announcement of information furnished to the SEC, typical of regulatory filings that do not fit into other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-04-18 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences LTD, pursuant to SEC rules. It contains a press release announcement about pursuing development of a treatment for Long COVID. The document is short (2847 characters) and primarily serves to furnish information rather than provide detailed financial data or comprehensive reports. It explicitly states that the information is furnished and not filed, indicating it is an announcement rather than a full report. There are no financial statements or substantive financial analysis present. Therefore, this document fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories and includes Form 6-K filings that are announcements or disclosures without detailed financial data.
2023-04-13 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences LTD, pursuant to SEC rules. It contains a press release announcement about presentations at a scientific conference, furnished as Exhibit 99.1. The document is short (2952 characters) and primarily serves to furnish information rather than provide a full report. It explicitly states that the information is furnished and not filed, indicating it is an announcement rather than a full report. There are no financial statements or substantive financial data included. Therefore, this document fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings and announcements that do not fit other categories.
2023-04-10 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an announcement about a podium presentation at a conference, furnished as an exhibit. The document is short (2898 characters) and primarily serves to announce the furnishing of information rather than containing substantive financial data or detailed reports. It does not contain financial statements or detailed analysis, nor is it a certification or officer attestation. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2023-04-04 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.